Shire Full Of Hopes For Vyvanse Binge-Eating Indication
This article was originally published in The Pink Sheet Daily
Executive Summary
First Phase II results in expansion program for the ADHD therapy show strong response in the eating disorder, but the company faces a regulatory challenge in gaining the first approval for the condition.